Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Vinpocetine

A semisynthetic derivative of vincamine, an alkaloid of the lesser periwinkle (Vinca minor): described in Hungary in 1975 and produced since 1978, it has been used for decades in Europe and Asia for disorders of brain circulation. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?The lesser periwinkle is a small evergreen plant with violet flowers, common in gardens: it is a relative of the Madagascar periwinkle, once called Vinca rosea, from which the anticancer drug vincristine is obtained.

VinpocetineGo to the active ingredient →
VinpocetineActive ingredientVinpocetineCat. No. P-V051-001CAS 42971-09-5

EDQM standards 5

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.